18 research outputs found

    Modelling Crop Evapotranspiration and Water Use Efficiency of Maize Using Artificial Neural Network and Linear Regression Models in Biochar and Inorganic Fertilizer-Amended Soil under Varying Water Applications

    Get PDF
    The deficit irrigation strategy is a well-known approach to optimize crop water use through the estimation of crop water use efficiency (CWUE). However, studies that comprehensively reported the prediction of crop evapotranspiration (ETc) and CWUE under deficit irrigation for improved water resources planning are scarce. The objective of the study is to predict seasonal ETc and CWUE of maize using multiple linear regression (MLR) and artificial neural network (ANN) models under two scenarios, i.e., (1) when only climatic parameters are considered and (2) when combining crop parameter(s) with climatic data in amended soil. Three consecutive field experimentations were carried out with biochar applied at rates of 0, 3, 6, 10 and 20 t/ha, while inorganic fertilizer was applied at rates of 0 and 300 Kg/ha, under three water regimes: 100% Full Irrigation Treatment (FIT), 80% and 60% FIT. Seasonal ETc was determined using the soil water balance method, while growth data were monitored weekly. The CWUE under each treatment was also estimated and modelled. The MLR and ANN models were developed, and their evaluations showed that the ANN model was satisfactory for the predictions of both ETc and CWUE under all soil water conditions and scenarios. However, the MLR model without crop data was poor in predicting CWUE under extreme soil water conditions (60% FIT). The coefficient of determination (R2) increased from 0.03 to 0.67, while root mean-square error (RMSE) decreased from 4.07 to 1.98 mm after the inclusion of crop data. The model evaluation suggests that using a simple model such as MLR, crop water productivity could be accurately predicted under different soil and water management conditions

    International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward

    Get PDF
    Background: Pediatric Post-COVID-Condition (PPCC) clinics treat children despite limited scientific substantiation. By exploring real-life management of children diagnosed with PPCC, the International Post-COVID-Condition in Children Collaboration (IP4C) aimed to provide guidance for future PPCC care. // Methods: We performed a cross-sectional international, multicenter study on used PPCC definitions; the organization of PPCC care programs and patients characteristics. We compared aggregated data from PPCC cohorts and identified priorities to improve PPCC care. // Results: Ten PPCC care programs and six COVID-19 follow-up research cohorts participated. Aggregated data from 584 PPCC patients was analyzed. The most common symptoms included fatigue (71%), headache (55%), concentration difficulties (53%), and brain fog (48%). Severe limitations in daily life were reported in 31% of patients. Most PPCC care programs organized in-person visits with multidisciplinary teams. Diagnostic testing for respiratory and cardiac morbidity was most frequently performed and seldom abnormal. Treatment was often limited to physical therapy and psychological support. // Conclusions: We found substantial heterogeneity in both the diagnostics and management of PPCC, possibly explained by scarce scientific evidence and lack of standardized care. We present a list of components which future guidelines should address, and outline priorities concerning PPCC care pathways, research and international collaboration

    Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

    Get PDF
    Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic
    corecore